| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0.001 | 0.996 | Dopamine D2 agonist | 0.995 0.001 CID_154699650 | ||
| 0.994 | 0.001 | 0.994 | Dopamine agonist | 0.994 0.001 CID_154699650 | ||
| 0.992 | 0.002 | 0.992 | 5 Hydroxytryptamine antagonist | 0.99 0.002 CID_154699650 | ||
| 0.991 | 0.001 | 0.991 | Alpha 2b adrenoreceptor antagonist | 0.867 0.002 CID_154699650 | ||
| 0.987 | 0.001 | 0.995 | 5 Hydroxytryptamine 2B antagonist | 0.995 0.001 CID_154699650 | CID_154699650 | |
| 0.985 | 0.001 | 0.985 | Alpha 2a adrenoreceptor antagonist | 0.74 0.003 CID_154699650 | ||
| 0.975 | 0.002 | 0.98 | Alpha adrenoreceptor antagonist | 0.98 0.002 CID_154699650 | CID_154699650 | |
| 0.975 | 0.003 | 0.975 | Antiadrenergic | 0.973 0.003 CID_154699650 | ||
| 0.975 | 0.003 | 0.975 | Adrenaline antagonist | 0.972 0.003 CID_154699650 | ||
| 0.969 | 0 | 0.969 | Prolactin release inhibitor | 0.959 0 CID_154699650 | ||
| 0.969 | 0.002 | 0.969 | Alpha 2 adrenoreceptor antagonist | 0.645 0.003 CID_154699650 | ||
| 0.965 | 0.002 | 0.965 | Dopamine D2 antagonist | 0.833 0.003 CID_154699650 | ||
| 0.964 | 0.002 | 0.981 | 5 Hydroxytryptamine 2 antagonist | 0.981 0.002 CID_154699650 | CID_154699650 | |
| 0.964 | 0.002 | 0.964 | 5 Hydroxytryptamine 1 antagonist | 0.886 0.002 CID_154699650 | ||
| 0.962 | 0.002 | 0.962 | Dopamine antagonist | 0.816 0.003 CID_154699650 | ||
| 0.959 | 0.001 | 0.959 | Dopamine D1 antagonist | 0.618 0.003 CID_154699650 | ||
| 0.959 | 0.001 | 0.959 | Alpha 2c adrenoreceptor antagonist | 0.801 0.002 CID_154699650 | ||
| 0.959 | 0.002 | 0.959 | 5 Hydroxytryptamine 2C antagonist | 0.775 0.003 CID_154699650 | ||
| 0.958 | 0.002 | 0.958 | 5 Hydroxytryptamine 1A antagonist | 0.873 0.003 CID_154699650 | ||
| 0.934 | 0.003 | 0.934 | Spasmolytic | 0.762 0.005 CID_154699650 | ||
| 0.926 | 0.002 | 0.926 | Alpha 1a adrenoreceptor antagonist | 0.777 0.003 CID_154699650 | ||
| 0.924 | 0.001 | 0.949 | 5 Hydroxytryptamine 1B agonist | 0.949 0.001 CID_154699650 | CID_154699650 | |
| 0.918 | 0.002 | 0.918 | 5 Hydroxytryptamine 7 antagonist | 0.888 0.002 CID_154699650 | ||
| 0.912 | 0.002 | 0.912 | Alpha 1 adrenoreceptor antagonist | 0.768 0.003 CID_154699650 | ||
| 0.898 | 0.002 | 0.898 | Dopamine D5 antagonist | 0.872 0.002 CID_154699650 | ||
| 0.887 | 0.002 | 0.887 | 5 Hydroxytryptamine 2A antagonist | 0.713 0.003 CID_154699650 | ||
| 0.885 | 0.003 | 0.885 | 5 Hydroxytryptamine agonist | 0.874 0.003 CID_154699650 | ||
| 0.881 | 0 | 0.881 | Prolactin inhibitor | 0.719 0 CID_154699650 | ||
| 0.856 | 0.004 | 0.856 | Nootropic | 0.837 0.004 CID_154699650 | ||
| 0.849 | 0.003 | 0.849 | P-glycoprotein inhibitor | 0.83 0.003 CID_154699650 | ||
| 0.845 | 0.002 | 0.845 | 5 Hydroxytryptamine 1F antagonist | 0.809 0.003 CID_154699650 | ||
| 0.833 | 0.002 | 0.833 | Alpha 1d adrenoreceptor antagonist | 0.658 0.003 CID_154699650 | ||
| 0.819 | 0.005 | 0.819 | Analgesic | 0.811 0.005 CID_154699650 | ||
| 0.811 | 0.003 | 0.821 | 5 Hydroxytryptamine 1 agonist | 0.821 0.003 CID_154699650 | CID_154699650 | |
| 0.804 | 0.002 | 0.804 | 5 Hydroxytryptamine 1B antagonist | 0.463 0.004 CID_154699650 | ||
| 0.772 | 0.002 | 0.772 | Alpha 1b adrenoreceptor antagonist | 0.506 0.004 CID_154699650 | ||
| 0.738 | 0.005 | 0.738 | Thioredoxin glutathione reductase inhibitor | 0.69 0.008 CID_154699650 | ||
| 0.728 | 0.003 | 0.728 | Cyclic AMP phosphodiesterase inhibitor | 0.572 0.005 CID_154699650 | ||
| 0.679 | 0.002 | 0.679 | Dopamine D3 agonist | 0.574 0.003 CID_154699650 | ||
| 0.676 | 0.003 | 0.676 | Alpha adrenoreceptor agonist | 0.222 0.007 CID_154699650 | ||
| 0.668 | 0.004 | 0.668 | Cholinergic antagonist | 0.357 0.01 CID_154699650 | ||
| 0.663 | 0.004 | 0.663 | Acetylcholine antagonist | 0.349 0.01 CID_154699650 | ||
| 0.587 | 0.006 | 0.61 | Vasodilator | 0.61 0.005 CID_154699650 | CID_154699650 | |
| 0.579 | 0.002 | 0.579 | 5 Hydroxytryptamine 2 agonist | 0.159 0.005 CID_154699650 | ||
| 0.563 | 0.003 | 0.563 | Dopamine D3 antagonist | 0.231 0.009 CID_154699650 | ||
| 0.531 | 0.012 | 0.531 | Hypoxia-inducible factor 1 alpha inhibitor | 0.307 0.062 CID_154699650 | ||
| 0.494 | 0.002 | 0.494 | 5 Hydroxytryptamine 2A agonist | 0.171 0.004 CID_154699650 | ||
| 0.491 | 0.004 | 0.491 | Acetylcholine M1 receptor antagonist | 0.304 0.014 CID_154699650 | ||
| 0.484 | 0.005 | 0.484 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.437 0.008 CID_154699650 | ||
| 0.46 | 0.004 | 0.46 | Opioid mu receptor antagonist | 0.379 0.004 CID_154699650 | ||
| 0.442 | 0.003 | 0.442 | 5 Hydroxytryptamine 2C agonist | 0.338 0.003 CID_154699650 | ||
| 0.442 | 0.004 | 0.442 | Opioid antagonist | 0.344 0.005 CID_154699650 | ||
| 0.395 | 0.002 | 0.395 | Dopamine D1 agonist | 0.333 0.002 CID_154699650 | ||
| 0.365 | 0.002 | 0.365 | 5 Hydroxytryptamine 4 antagonist | 0.311 0.002 CID_154699650 | ||
| 0.367 | 0.005 | 0.367 | Dopamine D4 antagonist | 0.107 0.024 CID_154699650 | ||
| 0.373 | 0.076 | 0.373 | Antiobesity | |||
| 0.275 | 0.004 | 0.275 | 5 Hydroxytryptamine 5A antagonist | 0.103 0.015 CID_154699650 | ||
| 0.261 | 0.005 | 0.261 | 5 Hydroxytryptamine 1D antagonist | 0.09 0.027 CID_154699650 | ||
| 0.253 | 0.014 | 0.253 | Acetylcholine muscarinic antagonist | 0.142 0.049 CID_154699650 | ||
| 0.24 | 0.004 | 0.24 | 5 Hydroxytryptamine 5 antagonist | 0.086 0.018 CID_154699650 | ||
| 0.238 | 0.007 | 0.238 | 5 Hydroxytryptamine 1A agonist | 0.117 0.013 CID_154699650 | ||
| 0.234 | 0.005 | 0.234 | Alpha 1 adrenoreceptor agonist | |||
| 0.208 | 0.004 | 0.208 | 5 Hydroxytryptamine 6 antagonist | 0.09 0.018 CID_154699650 | ||
| 0.195 | 0.014 | 0.195 | Androgen antagonist | 0.079 0.067 CID_154699650 | ||
| 0.18 | 0.003 | 0.293 | 5 Hydroxytryptamine 1D agonist | 0.293 0.002 CID_154699650 | CID_154699650 | |
| 0.256 | 0.086 | 0.256 | 5 Hydroxytryptamine release stimulant | |||
| 0.142 | 0.013 | 0.142 | Phosphodiesterase XI inhibitor | 0.092 0.039 CID_154699650 | ||
| 0.142 | 0.013 | 0.142 | Phosphodiesterase 11A inhibitor | 0.092 0.039 CID_154699650 | ||
| 0.138 | 0.018 | 0.138 | 5 Hydroxytryptamine uptake inhibitor | 0.08 0.034 CID_154699650 | ||
| 0.125 | 0.009 | 0.125 | Alpha 2 adrenoreceptor agonist | |||
| 0.155 | 0.05 | 0.155 | M18 aspartyl aminopeptidase inhibitor | 0.125 0.067 CID_154699650 | ||
| 0.125 | 0.023 | 0.125 | Adrenaline agonist | |||
| 0.154 | 0.068 | 0.154 | NOS3 expression enhancer | 0.122 0.111 CID_154699650 | ||
| 0.271 | 0.19 | 0.271 | Cyclophilin D inhibitor | |||
| 0.111 | 0.032 | 0.111 | Alpha 2d adrenoreceptor antagonist | 0.101 0.047 CID_154699650 | ||
| 0.142 | 0.064 | 0.142 | Phosphodiesterase inhibitor | |||
| 0.107 | 0.03 | 0.107 | Opioid kappa receptor antagonist | 0.074 0.068 CID_154699650 | ||
| 0.08 | 0.023 | 0.08 | Beta 3 adrenoreceptor antagonist | |||
| 0.069 | 0.017 | 0.069 | Nicotinic receptor alpha4 subunit antagonist | 0.053 0.029 CID_154699650 | ||
| 0.052 | 0.004 | 0.052 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 CID_154699650 | ||
| 0.162 | 0.115 | 0.162 | Platelet aggregation inhibitor | |||
| 0.14 | 0.093 | 0.14 | Sigma receptor agonist | |||
| 0.047 | 0.015 | 0.047 | p53 inhibitor | 0.034 0.026 CID_154699650 | ||
| 0.048 | 0.017 | 0.048 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 CID_154699650 | ||
| 0.047 | 0.022 | 0.047 | Somatostatin 1 antagonist | 0.035 0.03 CID_154699650 | ||
| 0.082 | 0.063 | 0.082 | Antineoplastic alkaloid | |||
| 0.047 | 0.03 | 0.047 | Phosphodiesterase 6C inhibitor | |||
| 0.052 | 0.041 | 0.069 | Protein kinase C eta inhibitor | 0.069 0.029 CID_154699650 | CID_154699650 | |
| 0.025 | 0.022 | 0.025 | Somatostatin 2 antagonist | |||
| 0.068 | 0.102 | 0.106 | Protein kinase C mu inhibitor | 0.106 0.052 CID_154699650 | CID_154699650 | |
| 0.157 | 0.221 | 0.227 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.227 0.128 CID_154699650 | CID_154699650 | |
| 0.024 | 0.153 | 0.069 | Antineoplastic antibiotic | 0.069 0.066 CID_154699650 | CID_154699650 | |
| 0.009 | 0.185 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_154699650 | CID_154699650 | |
| 0.028 | 0.353 | 0.182 | Chymotrypsin inhibitor | 0.182 0.011 CID_154699650 | CID_154699650 | |
| 0.008 | 0.53 | 0.057 | Plasminogen activator inhibitor | 0.057 0.042 CID_154699650 | CID_154699650 | |
| 0.016 | 0.728 | 0.069 | Kallikrein 7 inhibitor | 0.069 0.03 CID_154699650 | CID_154699650 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |